FRAZIER LIFE SCIENCES
Frazier Life Sciences invests in and builds companies developing and commercializing novel therapeutics at all stages, from company formation to public.
FRAZIER LIFE SCIENCES
Founded:
1991-01-01
Status:
Active
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-05-09 | Aspen Neuroscience | Frazier Life Sciences investment in Series B - Aspen Neuroscience | 147.5 M USD |
2022-04-07 | Trevi Therapeutics | Frazier Life Sciences investment in Post-IPO Equity - Trevi Therapeutics | 55 M USD |
More informations about "Frazier Life Sciences"
Frazier Life Sciences - Crunchbase Company Profile …
Frazier Life Sciences invests in and builds companies developing and commercializing novel therapeutics at all stages.See details»
Frazier Life Sciences Closes Oversubscribed $1.3 Billion Venture Fund
3 days ago Frazier Life Sciences has raised over $3.6 billion across five dedicated venture funds since 2016, alongside more than $1.7 billion raised in long-only public funds since 2021.See details»
Frazier Life Sciences - [LSUS] Life-Sciences-USA.com - The ...
Frazier Life Sciences invests globally in private and publicly traded companies that discover, develop, and commercialize innovative biopharmaceuticals. Frazier Life Sciences manages …See details»
Frazier Life Sciences raises $1.3 billion for latest fund
3 days ago Frazier Life Sciences announced Thursday that it raised $1.3 billion for its 12th fund — its largest to date — to back more biopharmaceutical startups.See details»
With $1.3 billion in hand, VC firm Frazier remains …
3 days ago VC firm Frazier Life Sciences has raised a $1.3 billion fund, the firm’s largest to date and one of the few new biotech investment funds raised amid the ongoing market upheaval.See details»
Team - Frazier Life Sciences
Our team is comprised of PhDs and MDs that have deep expertise in biopharmaceuticals and 675+ years of combined investing and operating experience.See details»
Frazier Life Sciences - Fundopedia
Oct 31, 2024 Frazier Life Sciences is a healthcare investment firm focusing on companies developing novel therapeutics. They invest across all stages of therapeutics companies …See details»
Frazier Life Sciences | LinkedIn
Frazier Life Sciences | 2,191 followers on LinkedIn. Investing in private & publicly-traded companies that discover, develop, and commercialize innovative biopharmaceuticals | Frazier …See details»
Frazier Life Sciences raises $1.3B for early-stage biotech fund
3 days ago Frazier Life Sciences gathered an impressive $1.3 billion in capital commitments for its twelfth venture fund aimed at private early-stage biotechs.See details»
Frazier Life Sciences Closes Oversubscribed $1.3 Billion Venture Fund
3 days ago Frazier Life Sciences has raised over $3.6 billion across five dedicated venture funds since 2016, alongside more than $1.7 billion raised in long-only public funds since 2021.See details»
Frazier Life Sciences raises over $1.3bn for 12th venture fund
3 days ago Frazier Life Sciences has raised over $3.6 billion across five venture funds since 2016. The firm’s investments include Mirum Pharmaceuticals, NewAmsterdam Pharma and …See details»
Frazier Life Sciences - Crunchbase Company Profile & Funding
Frazier Life Sciences invests globally in private and publicly-traded companies that discover and commercialize biopharmaceuticals.See details»
Strategy - Frazier Life Sciences
Frazier Life Sciences invests globally in companies discovering, developing, and commercializing novel therapeutics at all stages of development.See details»
Frazier Life Sciences Appoints James Li as Venture Partner
Dec 12, 2024 Frazier Life Sciences manages over $3.9 billion in capital, including Venture Funds focusing on company creation and private companies and the long-only Public Fund …See details»
Frazier Life Sciences » LaunchBio event
Jan 23, 2025 Frazier Life Sciences, a global biotherapeutics company, primarily invests in private and publicly traded companies that discover, develop, and commercialize innovative …See details»
Portfolio - Frazier Life Sciences
Our portfolio companies range from seed-stage startups to publicly traded companies and are advancing novel therapeutics for patients with a wide range of diseases.See details»
Frazier Life Sciences Closes Oversubscribed $1.3 Billion
3 days ago Frazier Life Sciences has raised over $3.6 billion across five dedicated venture funds since 2016, alongside more than $1.7 billion raised in long-only public funds since 2021.See details»
Frazier Life Sciences - Profiles & Contacts - Crunchbase
Frazier Life Sciences invests globally in private and publicly-traded companies that discover and commercialize biopharmaceuticals.See details»
News - Frazier Life Sciences
Apr 17, 2025 Frazier Life Sciences is a healthcare investment firm focusing on companies developing novel therapeutics. We have two core funds that enable investments across all …See details»
Frazier Life Sciences Names Gordon Empey as Chief Operating …
May 1, 2025 Palo Alto, Calif.– Frazier Life Sciences (FLS), a venture capital firm specializing in innovative therapeutics, has appointed Gordon Empey as Chief Operating Officer. Empey, …See details»